Nano-Bioregenerative Medical Institute, Hallym University, Chuncheon, Gangwon-do, Republic of Korea.
Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju 220-701, Republic of Korea.
Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:55-66. doi: 10.1016/j.msec.2018.12.021. Epub 2018 Dec 8.
The chronic kidney disease (CKD) patients are undergoing continuous ambulatory peritoneal dialysis (CAPD). However, there are some constraints, the frequent exchange of the dialysate and limitation of outside activity, associated with CAPD remain to be solved. In this study, we designed the wearable artificial kidney (WAK) system for peritoneal dialysis (PD) using urease-immobilized silk fibroin (SF) membrane and polymer-based spherical carbonaceous adsorbent (PSCA). We evaluated this kit's removal abilities of uremic toxins such as urea, creatinine, uric acid, phosphorus, and β2-microglobulin from the dialysate of end-stage renal disease (ESRD) patients in vitro. The uremic toxins including urea, creatinine, uric acid, and phosphorus were removed about 99% by immobilized SF membrane and PSCA filter after 24 h treatment. However, only 50% of β2-microglobulin was removed by this filtering system after 24 h treatment. In vivo study result shows that our filtering system has more uremic toxins removal efficiency than exchanged dialysate at every 6 h. We suggest that recirculating PD system using urease-immobilized SF membrane with PSCA could be more efficient than traditional dialysate exchange system for a WAK for PD.
慢性肾脏病(CKD)患者正在接受持续非卧床腹膜透析(CAPD)。然而,仍有一些限制需要解决,如频繁更换透析液和限制户外活动,这些与 CAPD 相关。在这项研究中,我们使用固定化脲酶的丝素蛋白(SF)膜和基于聚合物的球形碳质吸附剂(PSCA)设计了用于腹膜透析(PD)的可穿戴人工肾(WAK)系统。我们评估了该套件从终末期肾病(ESRD)患者透析液中去除尿毒症毒素(如尿素、肌酐、尿酸、磷和β2-微球蛋白)的能力。在 24 小时的治疗后,固定化 SF 膜和 PSCA 过滤器可将尿毒症毒素如尿素、肌酐、尿酸和磷去除约 99%。然而,只有 50%的β2-微球蛋白在 24 小时的治疗后被这种过滤系统去除。体内研究结果表明,与每 6 小时更换透析液相比,我们的过滤系统在每个时间点都具有更高的尿毒症毒素去除效率。我们建议,使用固定化脲酶的 SF 膜与 PSCA 的再循环 PD 系统可能比传统的透析液交换系统更适合作为 PD 的 WAK。